Catechin with Lactic Acid Bacteria Starters Enhances the Antiobesity Effect of Kimchi

J Med Food. 2023 Aug;26(8):560-569. doi: 10.1089/jmf.2023.K.0067. Epub 2023 Jul 3.

Abstract

The antiobesity effects of kimchi with catechin and lactic acid bacteria as starters were studied in C57BL/6 mice with high-fat diet (HFD)-induced obesity. We prepared four types of kimchi: commercial kimchi, standard kimchi, green tea functional kimchi, and catechin functional kimchi (CFK). Body weight and weight of adipose tissue were significantly lower in the kimchi-treated groups than in the HFD and Salt (HFD +1.5% NaCl) groups. In addition, in the CFK group, the serum levels of triglycerides, total cholesterol, and low-density lipoprotein cholesterol were significantly lower and those of high-density lipoprotein cholesterol were markedly higher than the corresponding levels in the HFD and Salt groups. Moreover, CFK reduced fat cells and crown-like structures in the liver and epididymal fat tissues. The protein expression of adipo/lipogenesis-related genes in the liver and epididymal fat tissues was significantly lower (1.90-7.48-fold) in the CFK group than in the HFD and Salt groups, concurrent with upregulation of lipolysis-related genes (1.71-3.38-fold) and downregulation of inflammation-related genes (3.17-5.06-fold) in epididymal fat tissues. In addition, CFK modulated the gut microbiomes of obese mice by increasing the abundance of Bacteroidetes (7.61%), while in contrast, Firmicutes (82.21%) decreased. In addition, the presence of the Erysipelotrichaceae (8.37%) family in the CFK group decreased, while the number of beneficial bacteria of the families, Akkermansiaceae (6.74%), Lachnospiraceae (14.95%), and Lactobacillaceae (38.41%), increased. Thus, CFK exhibited an antiobesity effect through its modulation of lipid metabolism and the microbiome.

Keywords: C57BL/6 mice; antiobesity; catechin; kimchi; lactic acid bacteria (LAB).

MeSH terms

  • Animals
  • Anti-Obesity Agents* / pharmacology
  • Catechin* / metabolism
  • Catechin* / pharmacology
  • Cholesterol
  • Diet, High-Fat / adverse effects
  • Fermented Foods*
  • Lactobacillales* / metabolism
  • Liver / metabolism
  • Mice
  • Mice, Inbred C57BL

Substances

  • Catechin
  • Anti-Obesity Agents
  • Cholesterol